BSE Live
Feb 06, 16:01Prev. Close
4010.60
Open Price
4003.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:54Prev. Close
4009.00
Open Price
4000.00
Bid Price (Qty.)
4000.90 (2)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Sanofi India (in Rs. Cr.) | Dec 24 | Dec 23 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 179.46 | 261.78 | |
| Diluted EPS (Rs.) | 179.46 | 261.78 | |
| Cash EPS (Rs.) | 195.65 | 279.35 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 374.17 | 441.39 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 374.17 | 441.39 | |
| Revenue from Operations/Share (Rs.) | 875.30 | 1,239.61 | |
| PBDIT/Share (Rs.) | 220.57 | 377.83 | |
| PBIT/Share (Rs.) | 204.61 | 360.61 | |
| PBT/Share (Rs.) | 187.57 | 367.61 | |
| Net Profit/Share (Rs.) | 179.70 | 262.13 | |
| NP After MI And SOA / Share (Rs.) | 179.70 | 262.13 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 25.19 | 30.47 | |
| PBIT Margin (%) | 23.37 | 29.09 | |
| PBT Margin (%) | 21.42 | 29.65 | |
| Net Profit Margin (%) | 20.52 | 21.14 | |
| NP After MI And SOA Margin (%) | 20.52 | 21.14 | |
| Return on Networth/Equity (%) | 48.02 | 59.38 | |
| Return on Capital Employed (%) | 52.72 | 77.98 | |
| Return on Assets (%) | 25.64 | 35.15 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 1.21 | 0.00 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.57 | 1.92 | |
| Quick Ratio (X) | 0.87 | 0.90 | |
| Inventory Turnover Ratio (X) | 0.61 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 139.85 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 131.23 | |
| Earnings Retention Ratio (%) | 0.00 | -39.85 | |
| Cash Earnings Retention Ratio (%) | 0.00 | -31.23 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 338.20 | 511.18 | |
| Interest Coverage Ratios (Post Tax) (%) | 338.20 | 511.18 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 13,783.39 | 18,147.83 | |
| EV/Net Operating Revenue (X) | 6.85 | 6.37 | |
| EV/EBITDA (X) | 27.17 | 20.88 | |
| MarketCap/Net Operating Revenue (X) | 6.99 | 6.51 | |
| Retention Ratios (%) | 0.00 | -39.85 | |
| Price/BV (X) | 16.36 | 18.28 | |
| Price/Net Operating Revenue | 6.99 | 6.51 | |
| Earnings Yield | 0.03 | 0.03 |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y